Scilex Holding (SCLXW) Cash & Current Investments (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Cash & Current Investments of $145.1 million in Q1 2026, up 1200.52% quarter-over-quarter from $11.2 million in Q4 2025, and up 2401.26% on a YoY basis from $5.8 million in Q1 2025.

Scilex Holding (SCLXW) Cash & Current Investments (2020 - 2026) Analysis & Trends

Scilex Holding's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $145.1 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 2401.26% year-over-year to $145.1 million; the TTM figure through Mar 2026 stood at $145.1 million (up 2401.26% YoY), while the FY2025 annual figure was $11.2 million, up 240.92% from the prior year.
  • Cash & Current Investments was $145.1 million for Q1 2026 at Scilex Holding, up from $11.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $145.1 million in Q1 2026 to a low of $69922.0 in Q3 2022.
  • Historically, Cash & Current Investments has averaged $29.9 million across 5 years, with a median of $4.1 million in 2025.
  • Biggest YoY gain for Cash & Current Investments was 55034.43% in 2022; the steepest drop was 98.48% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $2.2 million in 2022, then surged by 79.53% to $3.9 million in 2023, then dropped by 16.55% to $3.3 million in 2024, then surged by 240.92% to $11.2 million in 2025, then surged by 1200.52% to $145.1 million in 2026.
  • The last three Cash & Current Investments figures came in at $145.1 million (Q1 2026), $11.2 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 4.38 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.28 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 22.05 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 9.39 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 5.70 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 7.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 13.08 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 10.49 Bn
10 Scilex Holding - - 4.15 Mn 145.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 145.07 Mn
Dec 31, 2025 11.16 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.80 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 77,000.00
Jun 30, 2024 6.89 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 34.12 Mn
Mar 31, 2023 5.10 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 69,922.00
Jun 30, 2022 142.04 Mn
Mar 31, 2022 140.58 Mn
Dec 31, 2021 143.75 Mn
Sep 30, 2021 115,642.00
Jun 30, 2021 257,621.00